Chat with us, powered by LiveChat

Our blog

Explore the latest blogs from Lhasa

By 2025, 36% of world data will be healthcare data. (Yes, thirty-six percent!). Considering this statistic, now more than ever, it is …

The nitrosamine crisis first erupted in July 2018, when the FDA announced voluntary recall of several drugs containing Valsartan: a medicine used …

Hello, my name is Fabrizio Campo. I work in the Software Delivery department at Lhasa Limited, as a Junior Software Developer. My role aims …

With technical input from Andrew Thresher. Would your toxicology assessments benefit from free access to long-term carcinogenicity study data? The Lhasa Carcinogenicity …

When assessing the mutagenic potential of drug impurities in silico, the ICH M7 guideline states that two complementary (Q)SAR prediction methodologies should be …

Article written by Ally Reeves with top tips provided by Sara Atkinson. A key consideration within drug substance synthesis is the potential …